title: Impact of malnutrition and social determinants on survival of HIV-infected adults starting antiretroviral therapy in resource-limited settings.
abstract: OBJECTIVE
  Determining the impact of malnutrition, anaemia and social determinants on survival once starting antiretroviral therapy (ART) in a cohort of HIV-infected adults in a rural HIV care centre in Sihanoukville, Cambodia.
  
  
  METHODS
  Retrospective and descriptive cohort study of adults starting ART between December 2004 and July 2009. We used the Kaplan-Meier and Cox regression survival analyses to identify predictors of death.
  
  
  RESULTS
  Out of 1002 patients, 49.7% were men; median age was 40; median time of follow-up was 2.4 years and 10.4% died during the follow-up. At baseline, median CD4 cell count was 83 cells/μl, 79.9% were at WHO stage III or IV. In multivariate analysis, malnutrition appeared to be a strong and independent risk factor of death; 11.2% had a BMI less than 16 kg/m and hazard ratio was 6.97 [95% confidence interval (CI), 3.51-13.89], 21.5% had a BMI between 16 and 18 kg/m and hazard ratio was 2.88 (95% CI, 1.42-5.82), 30.8% had a BMI between 18 and 20 kg/m and hazard ratio was 2.18 (95% CI, 1.09-4.36). Severe anaemia (haemoglobin≤8.4 g/dl) and CD4 cell count below 100 cells/μl also predicted mortality, hazard ratio were 2.25 (95% CI, 1.02-4.34) and 2.29 (95% CI, 1.01-2.97), respectively. Social determinants were not significantly associated with death in univariate analysis.
  
  
  CONCLUSIONS
  Malnutrition and anaemia are strong and independent prognostic factors at the time of starting ART. Nutritional cares are essential for the clinical success of HIV programs started in developing countries.
authors.affiliation: Department of Infectious Diseases, Nouvel Hopital Civil, Strasbourg, France. xavier_argemi@hotmail.com
authors.forename: Xavier
authors.initials: X
authors.lastname: Argemi
authors.forename: Som
authors.initials: S
authors.lastname: Dara
authors.forename: Seng
authors.initials: S
authors.lastname: You
authors.forename: Jean F
authors.initials: JF
authors.lastname: Mattei
authors.forename: Christian
authors.initials: C
authors.lastname: Courpotin
authors.forename: Bernard
authors.initials: B
authors.lastname: Simon
authors.forename: Yves
authors.initials: Y
authors.lastname: Hansmann
authors.forename: Daniel
authors.initials: D
authors.lastname: Christmann
authors.forename: Nicolas
authors.initials: N
authors.lastname: Lefebvre
mesh_terms: D000328:Adult; D000740:Anemia / Q000150:complications / Q000401:mortality*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D002160:Cambodia / Q000453:epidemiology; D003906:Developing Countries; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000401:mortality*; D006801:Humans; D008297:Male; D044342:Malnutrition / Q000150:complications / Q000401:mortality*; D012189:Retrospective Studies; D012307:Risk Factors; D012423:Rural Health; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents